Transcriptional analysis of an E2F gene signature as a biomarker of activity of the cyclin-dependent kinase inhibitor PHA-793887 in tumor and skin biopsies from a phase I clinical study.

Source:http://linkedlifedata.com/resource/pubmed/id/20423997

Download in:

View as

General Info

PMID
20423997